|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.36 USD | -3.55% |
|
-2.16% | -49.63% |
Enlivex Therapeutics Ltd. (NasdaqCM:ENLV) announces a share repurchase program. Under the program, the company will repurchase up to $1.5 million worth of its shares. The share repurchase program is subject to the approval of the Economic Department of the Tel Aviv District Court.
The repurchase program is valid for 1 year.
| 1st Jan change | Capi. | |
|---|---|---|
| -49.63% | 29.43M | |
| +16.45% | 123B | |
| +21.96% | 115B | |
| +23.73% | 25.85B | |
| -20.05% | 20.9B | |
| -16.28% | 16.77B | |
| -16.52% | 16.52B | |
| -44.35% | 15.56B | |
| +63.91% | 15.49B | |
| +2.52% | 13.45B |
ENLIVEX THERAPEUTICS LTD. 
